Skip to main content
Erschienen in: Pediatric Nephrology 6/2023

03.11.2022 | Original Article

The cost of hospitalizations for treatment of hemodialysis catheter-associated blood stream infections in children: a retrospective cohort study

verfasst von: Heather L. Wasik, Alicia Neu, Bradley Warady, Brendan Crawford, Troy Richardson, Heidi G. De Souza, Diana Cardwell, Rebecca Ruebner, on behalf of the Standardizing Care to Improve Outcomes in Pediatric End-stage Kidney Disease (SCOPE) Investigators

Erschienen in: Pediatric Nephrology | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Hospitalization costs for treatment of hemodialysis (HD) catheter-associated blood stream infections (CA-BSI) in adults are high. No studies have evaluated hospitalization costs for HD CA-BSI in children or identified factors associated with high-cost hospitalizations.

Methods

We analyzed 160 HD CA-BSIs from the Standardizing Care to Improve Outcomes in Pediatric End-stage Kidney Disease (SCOPE) collaborative database linked to hospitalization encounters in the Pediatric Health Information System (PHIS) database. Charge-to-cost ratios were used to convert hospitalization charges reported in PHIS database to estimated hospital costs. Generalized linear mixed modeling was used to assess the relationship between higher-cost hospitalization (cost above 50th percentile) and patient and clinical characteristics. Generalized linear regression models were used to assess differences in mean service line costs between higher- and lower-cost hospitalizations.

Results

The median (IQR) length of stay for HD CA-BSI hospitalization was 5 (3–10) days. The median (IQR) cost for HD CA-BSI hospitalization was $18,375 ($11,584–$36,266). ICU stay (aOR 5.44, 95% CI 1.62–18.26, p = 0.01) and need for a catheter procedure (aOR = 6.08, 95% CI 2.45–15.07, p < 0.001) were associated with higher-cost hospitalization.

Conclusions

Hospitalizations for HD CA-BSIs in children are often multiple days and are associated with substantial costs. Interventions to reduce CA-BSI may reduce hospitalization costs for children who receive chronic HD.

Graphical abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Johansen KL, Chertow GM, Foley RN, Gilbertson DT, Herzog CA, Ishani A, Israni AK, Ku E, Tamura MK, & Li S (2021) US renal data system 2020 annual data report: Epidemiology of kidney disease in the united states. A J Kidney Diseases 77:A7–A8 Johansen KL, Chertow GM, Foley RN, Gilbertson DT, Herzog CA, Ishani A, Israni AK, Ku E, Tamura MK, & Li S (2021) US renal data system 2020 annual data report: Epidemiology of kidney disease in the united states. A J Kidney Diseases 77:A7–A8
8.
Zurück zum Zitat Fadrowski JJ, Hwang W, Frankenfield DL, Fivush BA, Neu AM, Furth SL (2006) Clinical course associated with vascular access type in a national cohort of adolescents who receive hemodialysis: findings from the clinical performance measures and US renal data system projects. Clin J Am Soc Nephrol 1:987–992. https://doi.org/10.2215/CJN.00530206CrossRefPubMed Fadrowski JJ, Hwang W, Frankenfield DL, Fivush BA, Neu AM, Furth SL (2006) Clinical course associated with vascular access type in a national cohort of adolescents who receive hemodialysis: findings from the clinical performance measures and US renal data system projects. Clin J Am Soc Nephrol 1:987–992. https://​doi.​org/​10.​2215/​CJN.​00530206CrossRefPubMed
11.
Zurück zum Zitat Marsenic O, Rodean J, Richardson T, Swartz S, Claes D, Day JC, Warady B, Neu A, Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Investigators (2020) Tunneled hemodialysis catheter care practices and blood stream infection rate in children: results from the SCOPE collaborative. Pediatr Nephrol 35:135–143. https://doi.org/10.1007/s00467-019-04384-7CrossRefPubMed Marsenic O, Rodean J, Richardson T, Swartz S, Claes D, Day JC, Warady B, Neu A, Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Investigators (2020) Tunneled hemodialysis catheter care practices and blood stream infection rate in children: results from the SCOPE collaborative. Pediatr Nephrol 35:135–143. https://​doi.​org/​10.​1007/​s00467-019-04384-7CrossRefPubMed
16.
Zurück zum Zitat Shwartz M, Young DW, Siegrist R (1995) The ratio of costs to charges: how good a basis for estimating costs? Inquiry 32:476–481PubMed Shwartz M, Young DW, Siegrist R (1995) The ratio of costs to charges: how good a basis for estimating costs? Inquiry 32:476–481PubMed
18.
Zurück zum Zitat Engemann J, Friedman J, Reed S, Griffiths R, Szczech L, Kaye K, Stryjewski M, Reller L, Schulman K, Corey G, Fowler V (2005) Clinical outcomes and costs due to staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26:534–539. https://doi.org/10.1086/502580CrossRefPubMed Engemann J, Friedman J, Reed S, Griffiths R, Szczech L, Kaye K, Stryjewski M, Reller L, Schulman K, Corey G, Fowler V (2005) Clinical outcomes and costs due to staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26:534–539. https://​doi.​org/​10.​1086/​502580CrossRefPubMed
28.
Zurück zum Zitat Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1–45. https://doi.org/10.1086/599376CrossRefPubMed Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1–45. https://​doi.​org/​10.​1086/​599376CrossRefPubMed
Metadaten
Titel
The cost of hospitalizations for treatment of hemodialysis catheter-associated blood stream infections in children: a retrospective cohort study
verfasst von
Heather L. Wasik
Alicia Neu
Bradley Warady
Brendan Crawford
Troy Richardson
Heidi G. De Souza
Diana Cardwell
Rebecca Ruebner
on behalf of the Standardizing Care to Improve Outcomes in Pediatric End-stage Kidney Disease (SCOPE) Investigators
Publikationsdatum
03.11.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 6/2023
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-022-05764-2

Weitere Artikel der Ausgabe 6/2023

Pediatric Nephrology 6/2023 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.